MAPT and type 2 diabetes mellitus: To assess the implication of tau on synaptic/cognitive deficits in T2DM, we used a genetic approach to ablate or overexpress tau levels in the db/db mice (Chen et al., 1996; Sharma, Elased, Garrett, & Lucot, 2010) (Figure S5A).